Celularity Inc

NAS:CELU (USA)   Ordinary Shares - Class A
$ 2.28 0 (0%) 11:09 PM EST
At Loss
P/B:
2.90
Market Cap:
$ 51.26M
Enterprise V:
$ 120.19M
Volume:
83.82K
Avg Vol (2M):
1.59M
Trade In:
Volume:
83.82K
At Loss
Avg Vol (2M):
1.59M

Business Description

Celularity Inc
NAICS : 325412 SIC : 2834
ISIN : US1511901050

Share Class Description:

CELU: Ordinary Shares - Class A
Description
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
Name Current Vs Industry Vs History
Equity-to-Asset 0.13
Debt-to-Equity 4
Debt-to-EBITDA -3.2
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.32
Distress
Grey
Safe
Beneish M-Score -2.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 50.53
9-Day RSI 48.01
14-Day RSI 47.87
6-1 Month Momentum % -10.1
12-1 Month Momentum % 53.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.19
Quick Ratio 0.14
Days Inventory 89.97
Days Sales Outstanding 75.99
Days Payable 292.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.5
Shareholder Yield % -19.28

Financials (Next Earnings Date:2025-01-03 Est.)

CELU's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CELU

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Celularity Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 48.2
EPS (TTM) ($) -1.567
Beta 0.92
Volatility % 114.11
14-Day RSI 47.87
14-Day ATR ($) 0.335197
20-Day SMA ($) 2.25375
12-1 Month Momentum % 53.33
52-Week Range ($) 1.3 - 7.97
Shares Outstanding (Mil) 22.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Celularity Inc Filings

Filing Date Document Date Form
No Filing Data

Celularity Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Celularity Inc Frequently Asked Questions

What is Celularity Inc(CELU)'s stock price today?
The current price of CELU is $2.28. The 52 week high of CELU is $7.97 and 52 week low is $1.30.
When is next earnings date of Celularity Inc(CELU)?
The next earnings date of Celularity Inc(CELU) is 2025-01-03 Est..
Does Celularity Inc(CELU) pay dividends? If so, how much?
Celularity Inc(CELU) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1